Profile data is unavailable for this security.
About the company
Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical formulations. The Company’s products include Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. Its Parenteral and Nasal Products has a range of products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostic, uterine stimulants, veterinary and other areas in the form of ampoules and vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. Its herbal products are useful for sore throat, prostate problems, and can be used as supplements for diabetes, obesity, libido and others. Its medical devices offer a C-Seal brand.
- Revenue in INR (TTM)1.58bn
- Net income in INR164.61m
- Incorporated1992
- Employees168.00
- LocationKilitch Drugs (India) LtdVillage: SavroliTaluka: Khalapur, Dist: RaigadMUMBAI 400088IndiaIND
- Phone+91 2 261214100
- Fax+91 2 267031658
- Websitehttps://www.kilitch.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brooks Laboratories Ltd | 781.93m | -198.55m | 3.64bn | 293.00 | -- | 6.15 | -- | 4.65 | -7.68 | -7.68 | 30.13 | 22.56 | 0.7934 | 5.44 | 3.96 | 2,668,713.00 | -20.15 | -13.86 | -27.57 | -22.90 | 31.35 | 26.19 | -25.40 | -27.47 | 0.9891 | 0.0688 | 0.1318 | -- | 25.76 | 7.63 | 6.26 | -- | -12.73 | -- |
| Medico Remedies Ltd | 1.41bn | 76.77m | 3.70bn | 193.00 | 48.74 | 6.67 | 34.83 | 2.62 | 0.9159 | 0.9159 | 16.88 | 6.69 | 1.40 | 6.35 | 2.63 | 7,318,264.00 | 7.63 | 6.15 | 14.54 | 12.40 | 26.19 | 25.26 | 5.44 | 3.99 | 1.40 | 11.24 | 0.1705 | -- | 3.19 | 8.21 | 14.49 | 39.49 | -7.58 | -- |
| Venus Remedies Ltd. | 6.15bn | 221.01m | 3.99bn | 1.19k | 18.04 | 0.8078 | 8.50 | 0.6495 | 16.56 | 16.56 | 461.13 | 369.72 | 0.945 | 2.68 | 8.72 | 5,178,093.00 | 3.40 | 4.82 | 4.06 | 6.17 | 39.06 | 38.90 | 3.60 | 5.58 | 2.69 | 1,660.39 | 0.0765 | -- | 8.27 | 13.32 | 7.25 | -- | 6.38 | -- |
| Kilitch Drugs (India) Ltd | 1.58bn | 164.61m | 4.92bn | 168.00 | 29.78 | 2.60 | 28.38 | 3.12 | 10.28 | 10.28 | 98.44 | 117.72 | 0.6347 | 26.77 | 2.29 | 9,377,369.00 | 5.70 | 3.38 | 7.93 | 4.76 | 34.75 | 35.33 | 8.98 | 6.17 | 2.01 | 2.81 | 0.1467 | 0.00 | 10.58 | 13.35 | 39.75 | 30.69 | -19.45 | -- |
| ZIM Laboratories Ltd | 3.88bn | 161.50m | 5.02bn | 556.00 | 31.14 | 2.07 | 14.80 | 1.29 | 3.31 | 3.31 | 79.19 | 49.82 | 0.9788 | 2.67 | 5.18 | 6,980,632.00 | 4.07 | 3.88 | 5.70 | 6.54 | 53.95 | 47.45 | 4.16 | 3.97 | 0.9475 | 2.77 | 0.3004 | 1.21 | -7.80 | 1.84 | -29.42 | 2.37 | 29.41 | -- |
| Lyka Labs Ltd | 1.32bn | 33.80m | 5.05bn | 423.00 | 153.48 | 5.11 | 40.80 | 3.84 | 0.9226 | 0.9226 | 37.94 | 27.71 | 0.8222 | 6.01 | 3.92 | 3,111,116.00 | 1.95 | -5.48 | 2.50 | -8.30 | 59.65 | 60.82 | 2.38 | -9.16 | 1.23 | 2.34 | 0.2627 | -- | 19.47 | 9.45 | 81.16 | -- | 13.88 | -- |
| Accent Microcell Ltd | 2.62bn | 325.33m | 5.06bn | 174.00 | 12.14 | 2.84 | 14.10 | 1.93 | 19.80 | 19.80 | 141.04 | 84.68 | 1.65 | 4.64 | 6.67 | 15,070,950.00 | 20.43 | -- | 24.77 | -- | 32.30 | -- | 12.41 | -- | 4.81 | -- | 0.0114 | -- | 24.45 | -- | 146.63 | -- | -- | -- |
| Medicamen Biotech Ltd | 1.82bn | 64.80m | 5.49bn | 378.00 | 60.80 | 2.53 | 39.76 | 3.02 | 7.10 | 7.10 | 165.42 | 170.67 | 0.6199 | 1.67 | 2.76 | 4,804,595.00 | 1.99 | 5.89 | 2.76 | 8.45 | 46.53 | 36.54 | 3.22 | 9.58 | 1.41 | 2.67 | 0.0854 | 8.46 | 27.29 | 7.90 | -26.36 | -1.89 | -16.71 | 0.00 |
| IND Swift Laboratories Ltd | 7.26bn | 3.73bn | 6.07bn | 47.00 | 1.62 | 0.600 | 1.52 | 0.836 | 63.24 | 63.24 | 123.25 | 171.20 | 0.486 | 1.73 | 2.54 | 154,462,200.00 | 25.01 | 5.00 | 29.88 | 6.13 | 46.23 | 41.12 | 51.47 | 8.52 | 3.51 | 7.87 | 0.016 | 0.00 | 6.10 | 11.10 | 784.44 | 70.82 | 23.60 | -- |
| Sakar Healthcare Ltd | 1.64bn | 124.03m | 6.20bn | 325.00 | 50.15 | 2.01 | 19.43 | 3.77 | 5.68 | 5.68 | 75.48 | 141.51 | 0.4312 | 3.22 | 7.45 | 5,052,619.00 | 3.25 | 5.26 | 3.85 | 6.28 | 44.83 | 43.47 | 7.55 | 10.12 | 0.6515 | 3.28 | 0.2374 | -- | 14.99 | 17.58 | -8.53 | 11.76 | 19.05 | -- |
